SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-061219
Filing Date
2024-05-16
Accepted
2024-05-16 17:30:13
Documents
2
Period of Report
2024-05-15

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1540
2 EX-24 cgem-ex24.htm EX-24 12209
  Complete submission text file 0000950170-24-061219.txt   15470
Mailing Address 3000 KENT AVENUE; SUITE A1-100 WEST LAFAYETTE IN 47906
Business Address
Meek David D. (Reporting) CIK: 0001555337 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39856 | Film No.: 24956938

Mailing Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142 617-410-4650
Cullinan Therapeutics, Inc. (Issuer) CIK: 0001789972 (see all company filings)

IRS No.: 813867811 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)